DepoMed Inc. (DEPO) posted third-quarter net income of $6.45 million or $0.11 per share, compared to $6.51 million or $0.11 per share in the prior-year quarter. Excluding items, adjusted net income for the latest quarter was $2.12 million or $0.03 per share.
Total revenues for the quarter increased to $51.49 million from $37.46 million in the same quarter last year. Product revenues surged 88 percent to a record $30.6 million from last year.
On average, analysts polled by Thomson Reuters expected the company to report a loss of $0.04 per share on revenues of $41.47 million for the quarter. Analysts' estimates typically exclude special items.
Looking ahead to fiscal 2014, the company expects adjusted earnings in a range of about $0.06 to $0.14 per share, compared to the prior guidance in the range of breakeven to $0.16 per share. The company also raised total revenue forecast to between about $232 million and $242 million from the previous projection between $215 million and $230 million.
Street is currently looking for earnings of $0.47 per share on annual revenues of $231.47 million.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.